EIF2AK4 and pulmonary venoocclusive disease: Nossent et al. reported that pulmonary artery remodeling and decreased GCN2 expression were the common denominators in all cases of PVOD and revealed a preponderant venous remodeling in young EIF2AK4 mutation carriers as compared with elder non-carriers [7].